EMCDDA

EU Drug Market: Drivers and facilitators

Report
 - 
EU Drug Market: Drivers and facilitators provides an overview of the key factors influencing the operation of the markets for illicit drugs in the European Union. It considers the changes and developments happening in the wider environment...

European Drug Report 2024: Trends and Developments

Report
The European Drug Report 2024: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report provides a comprehensive set of national...
Dashboard. Prevalence of cannabis use in Europe (updated June 2024)

Stimulants: health and social responses

Booklet
 - 
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview of what to consider when planning or delivering health and social responses to stimulant...

Introducing our new "Prevention Lists" resource!

News
 - 
We are excited to announce the latest addition to our Professional Development section—a dedicated area called "Prevention Lists." This resource is tailored for those keen on exploring evidence-based prevention programs and accessing...

European Drug Report 2023: Trends and Developments

Book
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national...

Launch event: European Drug Report 2023

 - 
Brussels

How many new drugs were detected in Europe over the last year? What are the latest trends in drug production and trafficking? What substances are causing the most concern today? Find out more when the European Monitoring Centre for Drugs and Drug

The future of drug monitoring in Europe until 2030

Book
 - 
Introduction Patterns of drug use and developments in the drug market in Europe are becoming more complex and dynamic, with major implications for drug monitoring and research. This observation prompted the European Monitoring Centre for...